Australian researchers at the University of Queensland’s Brain Institute have had success treating Alzheimer’s symptoms in mice with a combination of ultrasound and antibody drug therapy.
Though human trials of the technique have not yet been conducted, the results are seen as encouraging by researchers who also believe the technique could be applied to the treatment of other brain diseases such as Parkinson’s or Huntington’s disease.
What makes this trial unique is the use of ultrasound to open the blood brain barrier. This barrier usually stops drugs in the bloodstream from entering the brain and has been a major obstacle to the pharmacological treatment of neurological diseases.
The technique allows more of the medication to get into the brain to clear out the toxic proteins that cause Alzheimer’s.